Alternatives to Excalipoint Therapeutics

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Developing oral small molecule medicines for immunological and chronic diseases.

Clinical-stage biotech company targeting RNA modifications for novel cancer therapies.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Immunotherapy company targeting oncology and autoimmune diseases.

A biotechnology company focused on oncology drug discovery.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Advancing targeted alpha therapies.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.